EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

HomeAgenda
Register
Register
Register

ServiceUpdated on 9 September 2026

Preclinical services in Dermatology and inflammatory disorders

About

The SKINAXIS team works daily to support the development of your drug candidate or medical device and provide services that match your ambitions in dermatology for more than 20 years.

  • We offer a complete range of in vivo services, from standard to customized studies: POC, skin tolerance, PK/PD, biomarker discovery, to meet your specific needs. We support the development of your drugs and medical devices: inflammatory skin diseases (Psoriasis, Atopic Dermatitis, Eczema…), wound healing (acute and chronic wounds, multiple shape, size, depth in healthy or diabetic context), skin grafting (skin substitutes, organoids, biomimetic constructs; customizable size and shape, in immunocompetent or immunodeficient context), and dermal toxicity (acute, sub‑chronic, and chronic).

  • Bioanalytical services (IHC) and high‑performance imaging (dermoscopy).

  • We already contributed to the market launch of numerous innovative therapeutic products.

Type

  • Development
  • Consulting
  • Others

Applies to

  • Biotech and Lifescience
  • Medtech

Organisation

SYNCROSOME (ETAP SA)

Company (SME/startup) / 中小企業・スタートアップ

MARSEILLE, France